Form 8-K - Current report:
SEC Accession No. 0000950103-25-011676
Filing Date
2025-09-16
Accepted
2025-09-16 07:10:48
Documents
14
Period of Report
2025-09-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp234367_8k.htm   iXBRL 8-K 26455
2 EXHIBIT 99.1 dp234367_ex9901.htm EX-99.1 19156
6 GRAPHIC image_002.jpg GRAPHIC 3600
  Complete submission text file 0000950103-25-011676.txt   222337

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE crl-20250912.xsd EX-101.SCH 2996
4 XBRL LABEL FILE crl-20250912_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE crl-20250912_pre.xml EX-101.PRE 22347
16 EXTRACTED XBRL INSTANCE DOCUMENT dp234367_8k_htm.xml XML 3576
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

EIN.: 061397316 | Fiscal Year End: 1227
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 251315830
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)